These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35313093)

  • 1. Clinical and diagnostic features of anti-neurofascin-155 antibody-positive neuropathy in Han Chinese.
    Wang W; Liu C; Li W; Zhang D; Shan Y; Zheng J; Shan J; Zhao Y; Yan C; Wang Q
    Ann Clin Transl Neurol; 2022 May; 9(5):695-706. PubMed ID: 35313093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
    Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
    Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
    Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
    Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
    J Neurol; 2024 Aug; 271(8):4991-5002. PubMed ID: 38771386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
    Bai Y; Li W; Yan C; Hou Y; Wang Q
    Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
    Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
    Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody.
    Liu B; Zhou L; Sun C; Wang L; Zheng Y; Hu B; Qiao K; Zhao C; Lu J; Lin J
    Ann Clin Transl Neurol; 2023 Jun; 10(6):944-952. PubMed ID: 37060203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
    J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.
    Wang Z; Zhou X; Zhao N; Xie C; Zhu D; Guan Y
    Neurol Sci; 2021 Jun; 42(6):2223-2233. PubMed ID: 33782779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.
    Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC
    Muscle Nerve; 2018 May; 57(5):848-851. PubMed ID: 29130507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neurofascin 155 Antibody-positive Neuropathy in a Human Immunodeficiency Virus-infected Patient.
    Okubo S; Mano T; Sudo A; Goto R; Yano S; Hara M; Ishiura H; Satake W; Yanagimoto S; Ogata H; Toda T
    Intern Med; 2024 Feb; 63(4):565-569. PubMed ID: 37380455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
    Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
    Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
    Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
    Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
    Hu W; Xin Y; He Z; Zhao Y
    Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
    Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
    J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.
    Ogata H; Yamasaki R; Hiwatashi A; Oka N; Kawamura N; Matsuse D; Kuwahara M; Suzuki H; Kusunoki S; Fujimoto Y; Ikezoe K; Kishida H; Tanaka F; Matsushita T; Murai H; Kira J
    Ann Clin Transl Neurol; 2015 Oct; 2(10):960-71. PubMed ID: 26478896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
    Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
    Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
    Briani C; Salvalaggio A; Ruiz M; Cacciavillani M; Rinaldi F; Callegari I; Gasparotti R; Franciotta D
    J Neuroimmunol; 2019 May; 330():178-180. PubMed ID: 30713112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
    Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
    J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.